← Back to Search

Cochlear Implant

Cochlear Implants for Unilateral Hearing Loss

N/A
Recruiting
Research Sponsored by Med-El Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal or near-normal hearing in the non-implanted ear, as defined by a pure-tone average (500, 1000, 2000, and 4000 Hz) of 30 dB or less
65 years of age or older at the time of implantation
Must not have
External or middle ear infection
Evidence of severe cochlear malformation (i.e., common cavity or ossification)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year (12 months) post implantation
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether cochlear implants are safe and effective for seniors.

Who is the study for?
This trial is for adults over 65 with single-sided deafness who have tried other hearing aids without success. They must have profound hearing loss in one ear and normal or near-normal hearing in the other, not have had long-term deafness, no recent sudden hearing loss, and no issues that would make surgery risky.
What is being tested?
The study tests the safety and effectiveness of the MED-EL Cochlear Implant System in older adults with unilateral hearing loss. It aims to see if this implant can improve their ability to hear when traditional devices haven't worked well.
What are the potential side effects?
Potential side effects may include risks associated with surgery such as infection, issues related to anesthesia, inflammation around the implant site, changes in taste sensation due to nerve disturbance during implantation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hearing in the non-implanted ear is normal or almost normal.
Select...
I am 65 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have an infection in my outer or middle ear.
Select...
I have a severe inner ear abnormality.
Select...
I have a health condition that makes surgery or anesthesia risky for me.
Select...
I have had severe hearing loss for 10 years or more.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year (12 months) post implantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year (12 months) post implantation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Performance of the Cochlear Implant System will be assessed through speech perception testing in noise completed through one year (12 months) post implantation.
Secondary study objectives
Performance of the Cochlear Implant System will be assessed through speech perception testing in quiet completed through one year (12 months ) post implantation.
Performance of the Cochlear Implant System will be summarized through speech perception testing in noise completed through one year (12 months) post implantation.
Safety will be evaluated for all study subjects through one year (12 months) post implantation.
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study ProcedureExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Med-El CorporationLead Sponsor
24 Previous Clinical Trials
1,039 Total Patients Enrolled

Media Library

MED-EL Cochlear Implant System (Cochlear Implant) Clinical Trial Eligibility Overview. Trial Name: NCT05250414 — N/A
Unilateral Hearing Loss Research Study Groups: Study Procedure
Unilateral Hearing Loss Clinical Trial 2023: MED-EL Cochlear Implant System Highlights & Side Effects. Trial Name: NCT05250414 — N/A
MED-EL Cochlear Implant System (Cochlear Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05250414 — N/A
~2 spots leftby Jul 2025